August 27. 2010

• Four regional Italian pharmacovigilance databases show that moxifloxacin has the highest reporting rate of adverse events

August 20. 2010

• Mexican study shows levofloxacin is the most potent drug against Pseudomonas aeruginosa
• Absence of fluoroquinolone-resistance in patients with community-acquired pneumonia despite high fluroquinolone usage

August 12. 2010

• Biodegradable levofloxacin nanoparticles provide sustained ocular antibiotic delivery

August 5. 2010

• Bacteria carried by flies and cockroaches in Morocco are susceptible to levofloxacin
• New method for the simultaneous determination of levofloxacin, isoniazid and rifampicin in mouse tissues and plasma by HPLC-tandem MS

Return to 2010 Archive